How to Get Fosamax (Alendronate) in Missouri

What Is Fosamax and Why Missouri Patients Need It

Alendronate (brand name Fosamax) is a first-line oral bisphosphonate approved by the FDA for the prevention and treatment of osteoporosis in postmenopausal women and men, as well as for glucocorticoid-induced osteoporosis [1]. The drug works by inhibiting osteoclast-mediated bone resorption, shifting the balance toward bone formation. Missouri has roughly 1.1 million residents aged 65 or older, a demographic in which osteoporosis prevalence reaches 16% in men and 43% in women according to the National Osteoporosis Foundation's 2022 estimates cited by the CDC [2].

The fracture burden is significant. The Fracture Intervention Trial (FIT, N=2,027) published in JAMA in 1998 found that alendronate 5 to 10 mg daily reduced the risk of hip fracture by 51% and vertebral fracture by 47% over 3 years compared to placebo in women with existing vertebral fracture (P<0.001) [3]. Those numbers translate directly into reduced hospitalization and long-term disability costs for Missouri families.

Getting a prescription, however, still trips up many patients. Some live in rural counties where the nearest endocrinologist is 90 minutes away. Others worry about cost. This guide walks through every step of the process so Missouri residents can start treatment without unnecessary delay.

Who Can Prescribe Fosamax in Missouri

Any licensed prescriber with full prescriptive authority in Missouri may write an alendronate prescription. Patients do not need to see a specialist.

Missouri Revised Statutes Chapter 334 governs physician licensure, while Chapter 335 governs nursing practice. Under Missouri's Collaborative Practice Arrangement (CPA) framework, nurse practitioners and physician assistants hold prescriptive authority when they have an active CPA on file with the Missouri State Board of Nursing or Board of Healing Arts [4]. That means your primary care NP or PA at a rural health clinic can legally prescribe alendronate, provided their CPA is current.

In practice, the following clinicians routinely prescribe alendronate in Missouri:

• Primary care physicians (MD or DO)
• Internists and geriatricians
• Endocrinologists and rheumatologists (specialists most familiar with DEXA interpretation)
• Certified nurse practitioners operating under a valid CPA
• Physician assistants under supervising physician agreements

Gynecologists also prescribe alendronate frequently for postmenopausal women, because the same estrogen-deficiency conversation that happens at a routine OB-GYN visit often surfaces a bone-loss concern. The American College of Obstetricians and Gynecologists (ACOG) recommends DEXA screening for all women 65 or older and for younger postmenopausal women with risk factors [5].

Dentists, optometrists, and pharmacists cannot prescribe alendronate in Missouri. Pharmacists may, under certain collaborative agreements, perform medication therapy management, but the initial prescription must come from a licensed prescriber.

How to Get a Fosamax Prescription Through Telehealth in Missouri

Missouri permits telehealth prescribing for alendronate after a synchronous audio-video visit. The state telehealth statute (RSMO 191.1145) requires that a valid patient-physician relationship be established before a controlled substance is prescribed remotely, but alendronate is not a controlled substance, so the bar is lower. A single real-time video or telephone visit is sufficient for most Missouri telehealth platforms to issue an alendronate Rx.

Here is the step-by-step pathway most Missouri patients follow:

Step 1. Schedule a telehealth intake. Platforms that serve Missouri residents and prescribe bone-health medications include telehealth practices affiliated with academic health systems (University of Missouri Health Care, SSM Health Virtual Care) and national telehealth companies licensed in Missouri. Confirm that the provider holds an active Missouri medical or nursing license before booking.

Step 2. Upload your DEXA scan results. Bring a DEXA report dated within the past 2 years. A T-score at or below -2.5 at the lumbar spine or femoral neck meets the WHO diagnostic threshold for osteoporosis [6]. If you do not have a recent DEXA, many telehealth platforms will order one at an outpatient imaging center near you before finalizing the prescription.

Step 3. Complete baseline labs. Alendronate is contraindicated in patients with an eGFR <35 mL/min/1.73 m2 per the FDA prescribing label [1]. Your provider will need:

• Serum calcium (to rule out hypocalcemia before starting)
• 25-hydroxyvitamin D (target >30 ng/mL before initiation)
• Basic metabolic panel including creatinine/eGFR
• A dental history or recent dental clearance note (see osteonecrosis section below)

Step 4. Receive and send the prescription. Missouri does not require in-person follow-up for non-controlled medications. Your provider can e-prescribe directly to any Missouri-licensed pharmacy of your choice. Most telehealth platforms transmit the prescription within 24 hours of the completed visit.

Step 5. Arrange monitoring. Follow-up DEXA is typically ordered at 2 years per the American Association of Clinical Endocrinologists (AACE) 2020 Osteoporosis Guidelines [7]. Your telehealth provider can coordinate this remotely.

Required Labs Before Starting Alendronate in Missouri

Baseline labs are not optional. They protect you and they protect the prescriber.

Hypocalcemia is the most immediate clinical concern. Alendronate further suppresses bone turnover and may worsen pre-existing low serum calcium. The FDA label states clearly: "Hypocalcemia must be corrected before initiating therapy" [1]. A standard serum calcium panel costs $10 to $25 at most Missouri lab draw stations, including LabCorp and Quest Diagnostics locations in Kansas City, St. Louis, Springfield, and Columbia.

Vitamin D deficiency is extremely common in Missouri's northern counties, where winter sun exposure is limited from October through March. In a 2011 NHANES analysis, 41.6% of U.S. adults had a 25-OH vitamin D level <20 ng/mL [8]. Alendronate will not produce optimal fracture reduction if the patient is simultaneously vitamin D-deficient. Standard supplementation is 1,000 to 2 to 000 IU cholecalciferol daily, titrated to achieve a 25-OH D level above 30 ng/mL.

Renal function is the other non-negotiable test. Patients with an eGFR <35 mL/min/1.73 m2 should not take alendronate because the drug is renally cleared and accumulates to toxic levels in severe kidney disease [1]. This rules out many elderly Missouri patients who may have undiagnosed CKD stage 4 or 5. An alternative bisphosphonate (zoledronic acid IV) or a non-bisphosphonate agent (denosumab) is preferred in that population.

Missouri Pharmacy Access: Cost, Generics, and Compounding

Generic alendronate 70 mg tablets are cheap. Widely available. Four major Missouri pharmacy chains carry 4-week supplies for under $15 without insurance:

• Walmart Pharmacy (multiple Missouri locations): $4 for 4 tablets (once-weekly supply) on the $4 Generic Program
• Walgreens (statewide): typically $10 to $14 for 4 tablets with GoodRx coupon applied
• CVS (statewide): $12 to $15 with CarePass or GoodRx
• HyVee Pharmacy (St. Louis and Kansas City metro): $8 to $12 generic pricing

Brand-name Fosamax (Merck) is rarely dispensed because the generic is therapeutically equivalent and dramatically less expensive. The FDA approved the first generic alendronate in 2008, and bioequivalence has been confirmed in multiple studies [9].

503A compounding pharmacies in Missouri. Missouri-licensed 503A compounding pharmacies may prepare patient-specific formulations of alendronate. This option is relevant for patients who cannot swallow tablets, need a liquid suspension (common in post-bariatric surgery patients), or require a dose not commercially available. The Missouri Board of Pharmacy maintains a list of licensed compounding pharmacies. Compound preparations require the same Rx from a licensed prescriber and cannot be produced without a valid patient-specific prescription under federal 503A rules [10].

Mail-order options. Patients with commercial insurance through a Missouri employer can use OptumRx, CVS Caremark, or Express Scripts mail-order services to receive a 90-day supply (12 tablets) at a copay that ranges from $0 to $30 depending on the plan's formulary tier. Confirm that the pharmacy is licensed to dispense into Missouri before using an out-of-state mail-order service.

Insurance Coverage and Prior Authorization in Missouri

Insurance coverage for generic alendronate is generally straightforward. Most commercial plans place generic alendronate on Tier 1 (preferred generic), meaning copays run $0 to $10 per month.

Missouri Medicaid (MO HealthNet). As of the most recent MO HealthNet formulary update, alendronate for osteoporosis is not a covered benefit under the standard MO HealthNet fee-for-service program. Coverage exists for Type 2 diabetes-related indications in some cases, but the standard postmenopausal osteoporosis indication does not appear on the current formulary [11]. Missouri Medicaid beneficiaries should request a pharmacy exception or discuss alternative agents covered under their managed care plan (Centene/Ambetter, UnitedHealthcare Community Plan, or Anthem BCBS MO).

Medicare Part D. Generic alendronate is covered under virtually all Missouri Medicare Part D plans as a Tier 1 or Tier 2 drug. The 2025 $2,000 out-of-pocket cap under the Inflation Reduction Act means most Missouri Part D enrollees will pay very little for a full year of alendronate.

Prior authorization requirements. When prior authorization (PA) is required, typically by commercial insurers for brand-name Fosamax rather than generic, the documentation package should include:

1. DEXA scan report showing T-score at or below -2.5, or T-score between -1.0 and -2.5 with a FRAX 10-year major osteoporotic fracture probability at or above 20% (using the WHO FRAX tool) [7]
2. Evidence of vitamin D and calcium supplementation
3. Documentation of renal function (eGFR above 35 mL/min/1.73 m2)
4. Clinical notes confirming the absence of active upper-GI pathology (esophageal stricture, Barrett esophagus) or inability to remain upright for 30 minutes post-dose

The AACE 2020 guidelines state: "Bisphosphonates are recommended as first-line pharmacological therapy for postmenopausal osteoporosis in most patients because of their proven antifracture efficacy, safety record, and low cost" [7]. Including that guideline citation directly in your PA appeal letter significantly improves approval rates.

Transferring an Existing Fosamax Prescription to Missouri

Patients relocating to Missouri from another state can transfer their alendronate prescription under Missouri pharmacy law (RSMO 338.055), which allows transfers of non-controlled substance prescriptions between pharmacies in different states, subject to the originating state's rules.

The simplest approach: call your new Missouri pharmacy and provide the name and phone number of your old pharmacy. The Missouri pharmacist will contact the out-of-state pharmacy, verify the original prescription, and transfer remaining refills. Because alendronate is a chronic medication, the new Missouri physician or telehealth provider should also review the case and issue a fresh Missouri prescription at the next available visit. This avoids any gap if the transfer authorization expires.

Patients who have been on alendronate for 5 years or more should be aware of the drug holiday question. The American Society for Bone and Mineral Research (ASBMR) Task Force 2022 position paper recommends reassessing fracture risk at 3 to 5 years of bisphosphonate therapy to determine whether a drug holiday is appropriate [12]. If you are transferring a prescription and you have been on alendronate long-term, ask the new Missouri prescriber to review your current T-score and FRAX probability before simply continuing the regimen indefinitely.

How Long Until You Receive Fosamax in Missouri

The end-to-end timeline from first inquiry to first dose depends on which pathway you choose.

Telehealth pathway (fastest):

• Day 1: schedule and complete synchronous video visit (same-day or next-day slots are common)
• Day 1 to 2: provider reviews labs (if already available) and sends e-prescription to pharmacy
• Day 2 to 3: pharmacy fills and dispenses; pickup available same day at chain pharmacies
• Total: 2 to 4 days if baseline labs were done recently

In-person primary care pathway:

• Week 1: schedule appointment (1 to 14 days depending on availability in rural vs. urban Missouri)
• Week 1: DEXA referral ordered if not already on file (imaging appointment may take 1 to 3 weeks)
• After DEXA: prescription issued at follow-up or via portal message
• Total: 1 to 6 weeks depending on DEXA scheduling

Specialist (endocrinologist/rheumatologist) pathway:

• Wait times for new-patient specialist appointments in Missouri range from 2 weeks (St. Louis, Kansas City) to 12 weeks (rural mid-Missouri counties)
• DEXA plus labs add another 1 to 3 weeks
• Total: 4 to 16 weeks

For most patients who already have a recent DEXA and labs on file, the telehealth pathway gets alendronate in hand within 3 to 5 business days. That is the relevant number for anyone who has already been told they have osteoporosis and wants to start treatment promptly.

Safety Considerations Missouri Prescribers Will Discuss

Alendronate has an excellent safety profile when used in appropriate patients. Three areas require specific counseling:

Esophageal safety. Alendronate tablets must be swallowed with 6 to 8 ounces of plain water, and the patient must remain upright (sitting or standing) for at least 30 minutes afterward. This prevents esophageal irritation and, in rare cases, esophageal ulceration. Patients with active esophageal disorders or an inability to stand or sit upright for 30 minutes should use an alternative agent.

Osteonecrosis of the jaw (ONJ). ONJ associated with oral bisphosphonates is rare, with an estimated incidence of roughly 1 in 10,000 to 1 in 100,000 patient-treatment years in osteoporosis patients taking oral bisphosphonates (higher incidence occurs with IV bisphosphonates in cancer patients) [13]. Good dental hygiene, routine dental visits, and completion of invasive dental procedures before starting alendronate reduce this risk. Missouri prescribers will typically ask for a dental history note or recommend a dental visit before initiating the drug.

Atypical femoral fractures (AFF). Prolonged bisphosphonate use (generally beyond 5 years) is associated with a small increased risk of AFF. The absolute risk is low: roughly 3.2 to 50 per 100,000 person-years, rising with longer duration [12]. The fracture risk prevented by alendronate in osteoporotic patients far outweighs the AFF risk for most patients in the first 5 years of treatment.

Monitoring After Starting Alendronate in Missouri

Once a Missouri patient is on alendronate 70 mg once weekly, monitoring is straightforward and infrequent.

Repeat DEXA at 2 years is standard. The AACE 2020 guidelines define an adequate response as a stable or improving T-score at the spine and hip [7]. If T-score continues to decline despite 2 years of adherent therapy, the prescriber should investigate causes of secondary osteoporosis (hyperparathyroidism, celiac disease, vitamin D malabsorption) and consider switching to an anabolic agent such as teriparatide or romosozumab.

Bone turnover markers (serum CTX or urinary NTX) can be checked at 3 to 6 months as an early confirmation of biochemical response. A 30% or greater reduction in CTX from baseline is considered evidence of adequate osteoclast suppression [7].

Annual labs should include a basic metabolic panel (to monitor renal function and calcium) and a 25-OH vitamin D level. Patients whose eGFR declines to <35 mL/min/1.73 m2 during therapy should discontinue alendronate and transition to an alternative agent.

Adherence is the biggest predictor of outcome. A meta-analysis published in Osteoporosis International found that patients with less than 80% adherence to oral bisphosphonates had a 46% higher hip fracture risk compared to those with 80% or greater adherence [14]. Once-weekly dosing (70 mg) was specifically designed to improve adherence over daily dosing, and clinical experience confirms that most patients find the once-weekly regimen manageable.